Notice: This CMS-approved document has been submitted - Philips ...

More documents

Recommendations

Info

CMS-1403-FC Physi- cian Work Fully Implemented Non- Facility PE Year 2009 Transitional Non- Facility PE Fully Imple- mented Facility PE Year 2009 Transi- tional Facility PE 1 CPT codes and descriptions only are copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS apply. 2 If values are reflected for codes not payable by Medicare, please note that these values have been established as a courtesy to the general public and are not used for Medicare payment. 1328 Mal- Practice RVUs 2 Global CPT 1 / HCPCS Mod Status Description RVUs 2 RVUs 2 RVUs 2 RVUs 2 RVUs 2 88182 TC A Cell marker study 0.00 1.81 1.78 NA NA 0.04 XXX 88182 26 A Cell marker study 0.77 0.13 0.18 0.13 0.18 0.03 XXX 88184 A Flowcytometry/ tc, 1 marker 0.00 2.43 2.15 NA NA 0.02 XXX 88185 A Flowcytometry/tc, add-on 0.00 1.48 1.27 NA NA 0.02 ZZZ 88187 A Flowcytometry/read, 2-8 1.36 0.39 0.41 0.39 0.41 0.01 XXX 88188 A Flowcytometry/read, 9-15 1.69 0.47 0.49 0.47 0.49 0.01 XXX 88189 A Flowcytometry/read, 16 & > 2.23 0.48 0.55 0.48 0.55 0.01 XXX 88199 C Cytopathology procedure 0.00 0.00 0.00 NA NA 0.00 XXX 88199 TC C Cytopathology procedure 0.00 0.00 0.00 NA NA 0.00 XXX 88199 26 C Cytopathology procedure 0.00 0.00 0.00 0.00 0.00 0.00 XXX 88291 A Cyto/molecular report 0.52 0.28 0.25 0.28 0.25 0.02 XXX 88299 C Cytogenetic study 0.00 0.00 0.00 0.00 0.00 0.00 XXX 88300 A Surgical path, gross 0.08 0.56 0.54 NA NA 0.02 XXX 88300 TC A Surgical path, gross 0.00 0.54 0.51 NA NA 0.01 XXX 88300 26 A Surgical path, gross 0.08 0.02 0.03 0.02 0.03 0.01 XXX 88302 A Tissue exam by pathologist 0.13 1.23 1.18 NA NA 0.03 XXX 88302 TC A Tissue exam by pathologist 0.00 1.19 1.14 NA NA 0.02 XXX 88302 26 A Tissue exam by pathologist 0.13 0.04 0.04 0.04 0.04 0.01 XXX 88304 A Tissue exam by pathologist 0.22 1.48 1.45 NA NA 0.03 XXX 88304 TC A Tissue exam by pathologist 0.00 1.42 1.38 NA NA 0.02 XXX 88304 26 A Tissue exam by pathologist 0.22 0.06 0.07 0.06 0.07 0.01 XXX 88305 A Tissue exam by pathologist 0.75 2.10 2.06 NA NA 0.07 XXX 88305 TC A Tissue exam by pathologist 0.00 1.88 1.81 NA NA 0.04 XXX 88305 26 A Tissue exam by pathologist 0.75 0.22 0.25 0.22 0.25 0.03 XXX 88307 A Tissue exam by pathologist 1.59 4.33 4.05 NA NA 0.12 XXX 88307 TC A Tissue exam by pathologist 0.00 3.84 3.51 NA NA 0.06 XXX 88307 26 A Tissue exam by pathologist 1.59 0.49 0.54 0.49 0.54 0.06 XXX 88309 A Tissue exam by pathologist 2.80 6.15 5.72 NA NA 0.14 XXX 88309 TC A Tissue exam by pathologist 0.00 5.29 4.83 NA NA 0.06 XXX 88309 26 A Tissue exam by pathologist 2.80 0.86 0.89 0.86 0.89 0.08 XXX 88311 A Decalcify tissue 0.24 0.24 0.24 NA NA 0.02 XXX 88311 TC A Decalcify tissue 0.00 0.17 0.16 NA NA 0.01 XXX 88311 26 A Decalcify tissue 0.24 0.07 0.08 0.07 0.08 0.01 XXX 88312 A Special stains 0.54 2.34 2.14 NA NA 0.03 XXX 88312 TC A Special stains 0.00 2.19 1.97 NA NA 0.01 XXX 88312 26 A Special stains 0.54 0.15 0.17 0.15 0.17 0.02 XXX 88313 A Special stains 0.24 1.88 1.72 NA NA 0.02 XXX 88313 TC A Special stains 0.00 1.82 1.65 NA NA 0.01 XXX 88313 26 A Special stains 0.24 0.06 0.07 0.06 0.07 0.01 XXX 88314 A Histochemical stain 0.45 1.88 1.93 NA NA 0.04 XXX 88314 TC A Histochemical stain 0.00 1.74 1.78 NA NA 0.02 XXX 88314 26 A Histochemical stain 0.45 0.14 0.15 0.14 0.15 0.02 XXX 88318 A Chemical histochemistry 0.42 2.46 2.27 NA NA 0.03 XXX 88318 TC A Chemical histochemistry 0.00 2.35 2.14 NA NA 0.01 XXX 88318 26 A Chemical histochemistry 0.42 0.11 0.13 0.11 0.13 0.02 XXX 88319 A Enzyme histochemistry 0.53 3.14 3.21 NA NA 0.04 XXX 88319 TC A Enzyme histochemistry 0.00 2.98 3.04 NA NA 0.02 XXX 88319 26 A Enzyme histochemistry 0.53 0.16 0.17 0.16 0.17 0.02 XXX
CMS-1403-FC Physi- cian Work Fully Implemented Non- Facility PE Year 2009 Transitional Non- Facility PE Fully Imple- mented Facility PE Year 2009 Transi- tional Facility PE 1 CPT codes and descriptions only are copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS apply. 2 If values are reflected for codes not payable by Medicare, please note that these values have been established as a courtesy to the general public and are not used for Medicare payment. 1329 Mal- Practice RVUs 2 Global CPT 1 / HCPCS Mod Status Description RVUs 2 RVUs 2 RVUs 2 RVUs 2 RVUs 2 88321 A Microslide consultation 1.63 0.72 0.74 0.48 0.50 0.05 XXX 88323 A Microslide consultation 1.83 2.09 2.02 NA NA 0.07 XXX 88323 TC A Microslide consultation 0.00 1.64 1.54 NA NA 0.02 XXX 88323 26 A Microslide consultation 1.83 0.45 0.48 0.45 0.48 0.05 XXX 88325 A Comprehensive review of data 2.50 2.54 2.64 0.78 0.82 0.07 XXX 88329 A Path consult introp 0.67 0.67 0.66 0.21 0.23 0.02 XXX 88331 A Path consult intraop, 1 bloc 1.19 1.22 1.19 NA NA 0.08 XXX 88331 TC A Path consult intraop, 1 bloc 0.00 0.83 0.77 NA NA 0.04 XXX 88331 26 A Path consult intraop, 1 bloc 1.19 0.39 0.42 0.39 0.42 0.04 XXX 88332 A Path consult intraop, addÆl 0.59 0.46 0.47 NA NA 0.04 XXX 88332 TC A Path consult intraop, addÆl 0.00 0.28 0.27 NA NA 0.02 XXX 88332 26 A Path consult intraop, addÆl 0.59 0.18 0.20 0.18 0.20 0.02 XXX 88333 A Intraop cyto path consult, 1 1.20 1.29 1.24 NA NA 0.08 XXX 88333 TC A Intraop cyto path consult, 1 0.00 0.92 0.83 NA NA 0.04 XXX 88333 26 A Intraop cyto path consult, 1 1.20 0.37 0.41 0.37 0.41 0.04 XXX 88334 A Intraop cyto path consult, 2 0.73 0.79 0.75 NA NA 0.04 XXX 88334 TC A Intraop cyto path consult, 2 0.00 0.56 0.51 NA NA 0.02 XXX 88334 26 A Intraop cyto path consult, 2 0.73 0.23 0.24 0.23 0.24 0.02 XXX 88342 A Immunohistochemistry 0.85 1.94 1.82 NA NA 0.05 XXX 88342 TC A Immunohistochemistry 0.00 1.71 1.56 NA NA 0.02 XXX 88342 26 A Immunohistochemistry 0.85 0.23 0.26 0.23 0.26 0.03 XXX 88346 A Immunofluorescent study 0.86 1.89 1.82 NA NA 0.05 XXX 88346 TC A Immunofluorescent study 0.00 1.65 1.55 NA NA 0.02 XXX 88346 26 A Immunofluorescent study 0.86 0.24 0.27 0.24 0.27 0.03 XXX 88347 A Immunofluorescent study 0.86 1.25 1.25 NA NA 0.05 XXX 88347 TC A Immunofluorescent study 0.00 1.07 1.03 NA NA 0.02 XXX 88347 26 A Immunofluorescent study 0.86 0.18 0.22 0.18 0.22 0.03 XXX 88348 A Electron microscopy 1.51 17.47 15.48 NA NA 0.13 XXX 88348 TC A Electron microscopy 0.00 17.05 15.00 NA NA 0.07 XXX 88348 26 A Electron microscopy 1.51 0.42 0.48 0.42 0.48 0.06 XXX 88349 A Scanning electron microscopy 0.76 8.52 7.30 NA NA 0.09 XXX 88349 TC A Scanning electron microscopy 0.00 8.29 7.04 NA NA 0.06 XXX 88349 26 A Scanning electron microscopy 0.76 0.23 0.26 0.23 0.26 0.03 XXX 88355 A Analysis, skeletal muscle 1.85 3.16 4.57 NA NA 0.13 XXX 88355 TC A Analysis, skeletal muscle 0.00 2.78 4.09 NA NA 0.06 XXX 88355 26 A Analysis, skeletal muscle 1.85 0.38 0.48 0.38 0.48 0.07 XXX 88356 A Analysis, nerve 3.02 4.91 4.73 NA NA 0.19 XXX 88356 TC A Analysis, nerve 0.00 4.40 4.04 NA NA 0.07 XXX 88356 26 A Analysis, nerve 3.02 0.51 0.69 0.51 0.69 0.12 XXX 88358 A Analysis, tumor 0.95 1.09 1.03 NA NA 0.17 XXX 88358 TC A Analysis, tumor 0.00 0.93 0.81 NA NA 0.07 XXX 88358 26 A Analysis, tumor 0.95 0.16 0.22 0.16 0.22 0.10 XXX 88360 A Tumor immunohistochem/manual 1.10 2.24 2.11 NA NA 0.08 XXX 88360 TC A Tumor immunohistochem/manual 0.00 1.95 1.78 NA NA 0.02 XXX 88360 26 A Tumor immunohistochem/manual 1.10 0.29 0.33 0.29 0.33 0.06 XXX 88361 A Tumor immunohistochem/comput 1.18 2.73 2.82 NA NA 0.17 XXX 88361 TC A Tumor immunohistochem/comput 0.00 2.46 2.49 NA NA 0.07 XXX 88361 26 A Tumor immunohistochem/comput 1.18 0.27 0.33 0.27 0.33 0.10 XXX
Page 1 and 2:
Notice: This CMS-approved document
Page 3 and 4:
CMS-1403-FC 3 1. Electronically. Yo
Page 5 and 6:
CMS-1403-FC 5 FOR FURTHER INFORMATI
Page 7 and 8:
CMS-1403-FC 7 Trisha Brooks, (410)7
Page 9 and 10:
CMS-1403-FC 9 ● The physician sel
Page 11 and 12:
CMS-1403-FC 11 Schedule C. Malpract
Page 13 and 14:
CMS-1403-FC 13 3. Beneficiary Signa
Page 15 and 16:
CMS-1403-FC 15 A. Summary of Issues
Page 17 and 18:
CMS-1403-FC 17 XIII. Waiver of Prop
Page 19 and 20:
CMS-1403-FC 19 BBRA [Medicare, Medi
Page 21 and 22:
CMS-1403-FC 21 E/M Evaluation and m
Page 23 and 24:
CMS-1403-FC 23 MA-PD Medicare Advan
Page 25 and 26:
CMS-1403-FC 25 OSCAR Online Survey
Page 27 and 28:
CMS-1403-FC 27 WAMP Widely availabl
Page 29 and 30:
CMS-1403-FC 29 2. Practice Expense
Page 31 and 32:
CMS-1403-FC 31 extent practicable a
Page 33 and 34:
CMS-1403-FC 33 AMA's Current Proced
Page 35 and 36:
CMS-1403-FC 35 Payment = [(RVU work
Page 37 and 38:
CMS-1403-FC 37 legislation, the PFS
Page 39 and 40:
CMS-1403-FC that time, PE RVUs were
Page 41 and 42:
CMS-1403-FC utilize a “bottom-up
Page 43 and 44:
CMS-1403-FC ● All other expenses,
Page 45 and 46:
CMS-1403-FC b. Allocation of PE to
Page 47 and 48:
CMS-1403-FC combined survey data fr
Page 49 and 50:
CMS-1403-FC for the global componen
Page 51 and 52:
CMS-1403-FC equipment cost per minu
Page 53 and 54:
CMS-1403-FC components), then the i
Page 55 and 56:
CMS-1403-FC indirect PE for all PFS
Page 57 and 58:
CMS-1403-FC • Physical therapy ut
Page 59 and 60:
CMS-1403-FC TABLE 1: Calculation of
Page 61 and 62:
CMS-1403-FC 2. PE Proposals for CY
Page 63 and 64:
CMS-1403-FC The formula for estimat
Page 65 and 66:
CMS-1403-FC arbitrary method for ch
Page 67 and 68:
CMS-1403-FC We received no comments
Page 69 and 70:
CMS-1403-FC (iv) Contractor Pricing
Page 71 and 72:
CMS-1403-FC Response: We will ask t
Page 73 and 74:
Code CMS-1403-FC 2008/9 Description
Page 75 and 76:
CMS-1403-FC TABLE 4: Practice Expen
Page 77 and 78:
CMS-1403-FC B. Geographic Practice
Page 79 and 80:
CMS-1403-FC services, and are adjus
Page 81 and 82:
CMS-1403-FC by at least 5 percent,
Page 83 and 84:
CMS-1403-FC we decided not to proce
Page 85 and 86:
CMS-1403-FC so as part of the CY 20
Page 87 and 88:
CMS-1403-FC In the CY 2008 PFS fina
Page 89 and 90:
CMS-1403-FC are available, we would
Page 91 and 92:
CMS-1403-FC is no duplication of co
Page 93 and 94:
CMS-1403-FC practitioner) at the di
Page 95 and 96:
CMS-1403-FC PFS final rule with com
Page 97 and 98:
CMS-1403-FC individual MNT (or any
Page 99 and 100:
CMS-1403-FC Group DSMT (which compr
Page 101 and 102:
CMS-1403-FC The acuity of a critica
Page 103 and 104:
CMS-1403-FC needed regarding a crit
Page 105 and 106:
CMS-1403-FC errors; enhanced patien
Page 107 and 108:
CMS-1403-FC 99233). For CY 2006, we
Page 109 and 110:
CMS-1403-FC follow-up inpatient con
Page 111 and 112:
CMS-1403-FC As noted previously, CP
Page 113 and 114:
CMS-1403-FC face-to-face encounter
Page 115 and 116:
CMS-1403-FC visits requested by the
Page 117 and 118:
CMS-1403-FC Follow-up inpatient tel
Page 119 and 120:
CMS-1403-FC that were appropriate t
Page 121 and 122:
CMS-1403-FC HCPCS codes 96150 throu
Page 123 and 124:
CMS-1403-FC G0332). The Medicare pa
Page 125 and 126:
CMS-1403-FC code G0332. For CY 2009
Page 127 and 128:
CMS-1403-FC Response: The separate
Page 129 and 130:
CMS-1403-FC preadministration-relat
Page 131 and 132:
CMS-1403-FC pricing of IVIG and Med
Page 133 and 134:
CMS-1403-FC CPT Code Short Descript
Page 135 and 136:
CMS-1403-FC percent for the subsequ
Page 137 and 138:
CMS-1403-FC in the same session, on
Page 139 and 140:
CMS-1403-FC jeopardizes beneficiary
Page 141 and 142:
CMS-1403-FC As discussed in the pro
Page 143 and 144:
CMS-1403-FC Note: Under the PFS, CP
Page 145 and 146:
CMS-1403-FC The methodology for dev
Page 147 and 148:
CMS-1403-FC drugs furnished through
Page 149 and 150:
CMS-1403-FC Response: We disagree w
Page 151 and 152:
CMS-1403-FC available to support a
Page 153 and 154:
CMS-1403-FC that there are complica
Page 155 and 156:
CMS-1403-FC administered to a benef
Page 157 and 158:
CMS-1403-FC as we assess potential
Page 159 and 160:
CMS-1403-FC add a modifier to their
Page 161 and 162:
CMS-1403-FC application of the AQ m
Page 163 and 164:
CMS-1403-FC 0.7000. ● A reduction
Page 165 and 166:
CMS-1403-FC so the CY 2009 base com
Page 167 and 168:
CMS-1403-FC patient utilization gro
Page 169 and 170:
CMS-1403-FC make those estimates. A
Page 171 and 172:
CMS-1403-FC After removing the enro
Page 173 and 174:
CMS-1403-FC For CY 2009, we propose
Page 175 and 176:
CMS-1403-FC plain language over pol
Page 177 and 178:
CMS-1403-FC four quarters of ASP pr
Page 179 and 180:
CMS-1403-FC composite rates. The wa
Page 181 and 182:
CMS-1403-FC from the figure in the
Page 183 and 184:
CMS-1403-FC that our goal is the ev
Page 185 and 186:
CMS-1403-FC the average wage index
Page 187 and 188:
CMS-1403-FC Labor Statistics, to de
Page 189 and 190:
CMS-1403-FC been previously deemed
Page 191 and 192:
CMS-1403-FC CBSA where the campuses
Page 193 and 194:
CMS-1403-FC composite rates during
Page 195 and 196:
CMS-1403-FC target amount of compos
Page 197 and 198:
CMS-1403-FC admission. That is, the
Page 199 and 200:
CMS-1403-FC that CMS consider issue
Page 201 and 202:
CMS-1403-FC hold the provider in wh
Page 203 and 204:
CMS-1403-FC Comment: Commenters rai
Page 205 and 206:
CMS-1403-FC who have enrolled in th
Page 207 and 208:
CMS-1403-FC ● Posting IDTF standa
Page 209 and 210:
CMS-1403-FC other diagnostic testin
Page 211 and 212:
CMS-1403-FC entities furnishing mob
Page 213 and 214:
CMS-1403-FC state Radioactive Mater
Page 215 and 216:
CMS-1403-FC equipment and provide t
Page 217 and 218:
CMS-1403-FC Response: We understand
Page 219 and 220:
CMS-1403-FC believe that requiring
Page 221 and 222:
CMS-1403-FC these claims will ensur
Page 223 and 224:
CMS-1403-FC and NPP organizations,
Page 225 and 226:
CMS-1403-FC prior to their enrollin
Page 227 and 228:
CMS-1403-FC The date of approval is
Page 229 and 230:
CMS-1403-FC organizations, and indi
Page 231 and 232:
CMS-1403-FC To assist physician and
Page 233 and 234:
CMS-1403-FC Comment: Several commen
Page 235 and 236:
CMS-1403-FC date of filing and circ
Page 237 and 238:
CMS-1403-FC services are complying
Page 239 and 240:
CMS-1403-FC days when a Presidentia
Page 241 and 242:
CMS-1403-FC effective date under ap
Page 243 and 244:
CMS-1403-FC Comment: The suggestion
Page 245 and 246:
CMS-1403-FC Response: We thank the
Page 247 and 248:
CMS-1403-FC provider enrollment giv
Page 249 and 250:
CMS-1403-FC instead, it will force
Page 251 and 252:
CMS-1403-FC Response: As stated abo
Page 253 and 254:
CMS-1403-FC Comment: One commenter
Page 255 and 256:
CMS-1403-FC In an attempt to ensure
Page 257 and 258:
CMS-1403-FC rule, rather than limit
Page 259 and 260:
CMS-1403-FC changes have occurred,
Page 261 and 262:
CMS-1403-FC Response: While we moni
Page 263 and 264:
CMS-1403-FC records faster and more
Page 265 and 266:
CMS-1403-FC In §424.521(a)(1), we
Page 267 and 268:
CMS-1403-FC practitioners with the
Page 269 and 270:
CMS-1403-FC In June 2002 and Novemb
Page 271 and 272:
CMS-1403-FC full implementation sch
Page 273 and 274:
CMS-1403-FC with billing agents, cl
Page 275 and 276:
CMS-1403-FC 2. Medicare Billing Pri
Page 277 and 278:
CMS-1403-FC The FPLP is a collectio
Page 279 and 280:
CMS-1403-FC continued enrollment to
Page 281 and 282:
CMS-1403-FC Federal Payment Levy Pr
Page 283 and 284:
CMS-1403-FC Consistent with existin
Page 285 and 286:
CMS-1403-FC facilitate the enrollme
Page 287 and 288:
CMS-1403-FC determination. Specific
Page 289 and 290:
CMS-1403-FC individual practitioner
Page 291 and 292:
CMS-1403-FC determines in February
Page 293 and 294:
CMS-1403-FC Management Manual (IOM
Page 295 and 296:
CMS-1403-FC Response: Based on thes
Page 297 and 298:
CMS-1403-FC or continues to meet th
Page 299 and 300:
CMS-1403-FC to identify and discipl
Page 301 and 302:
Page 303 and 304:
CMS-1403-FC save our severe penalti
Page 305 and 306:
Page 307 and 308:
CMS-1403-FC affords the supplier ap
Page 309 and 310:
CMS-1403-FC privileges and assess a
Page 311 and 312:
CMS-1403-FC §424.535(a)(10) that w
Page 313 and 314:
CMS-1403-FC documentation for 7 yea
Page 315 and 316:
CMS-1403-FC pharmacies to follow re
Page 317 and 318:
Page 319 and 320:
CMS-1403-FC practitioners, includin
Page 321 and 322:
CMS-1403-FC that require a revoked
Page 323 and 324:
CMS-1403-FC provider and supplier e
Page 325 and 326:
CMS-1403-FC K. Amendment to the Exe
Page 327 and 328:
CMS-1403-FC Prescription Fill Statu
Page 329 and 330:
CMS-1403-FC dispensers to move towa
Page 331 and 332:
CMS-1403-FC Following the publicati
Page 333 and 334:
CMS-1403-FC does not respond to the
Page 335 and 336:
CMS-1403-FC facsimiles in all insta
Page 337 and 338:
CMS-1403-FC Similarly, other commen
Page 339 and 340:
CMS-1403-FC proposed rule's publica
Page 341 and 342:
CMS-1403-FC elimination of the comp
Page 343 and 344:
CMS-1403-FC exemption originally cr
Page 345 and 346:
CMS-1403-FC dispensers are not requ
Page 347 and 348:
CMS-1403-FC products, or, where upg
Page 349 and 350:
CMS-1403-FC take time to develop, a
Page 351 and 352:
CMS-1403-FC integrated this technol
Page 353 and 354:
CMS-1403-FC Version 10.2 or higher)
Page 355 and 356:
CMS-1403-FC proposed January 2009 c
Page 357 and 358:
CMS-1403-FC L. Comprehensive Outpat
Page 359 and 360:
CMS-1403-FC examination. In order t
Page 361 and 362:
CMS-1403-FC qualifications for HHAs
Page 363 and 364:
CMS-1403-FC distinction in the lice
Page 365 and 366:
CMS-1403-FC (2) Have successfully c
Page 367 and 368:
CMS-1403-FC risk-taking behaviors,
Page 369 and 370:
CMS-1403-FC Therefore, we proposed
Page 371 and 372:
CMS-1403-FC commenter stated that o
Page 373 and 374:
CMS-1403-FC psychological services
Page 375 and 376:
CMS-1403-FC 3. CORF Conditions of P
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
CMS-1403-FC The following is a summ
Page 383 and 384:
CMS-1403-FC We are not making any c
Page 385 and 386:
CMS-1403-FC N. Physician Self-Refer
Page 387 and 388:
CMS-1403-FC arrangements, and the l
Page 389 and 390:
CMS-1403-FC below are related to ea
Page 391 and 392:
CMS-1403-FC clinical practice. With
Page 393 and 394:
CMS-1403-FC In the CY 2009 PFS prop
Page 395 and 396:
CMS-1403-FC would be outside the sc
Page 397 and 398:
CMS-1403-FC reflect objective quali
Page 399 and 400:
CMS-1403-FC quality resulting from
Page 401 and 402:
CMS-1403-FC payments should be reas
Page 403 and 404:
CMS-1403-FC changes in referral pat
Page 405 and 406:
CMS-1403-FC the alternative, we pro
Page 407 and 408:
CMS-1403-FC finalize this condition
Page 409 and 410:
CMS-1403-FC and “quality maintena
Page 411 and 412:
CMS-1403-FC date. We seek comments
Page 413 and 414:
CMS-1403-FC existing exceptions to
Page 415 and 416:
CMS-1403-FC our general rulemaking
Page 417 and 418:
CMS-1403-FC these approaches. We pr
Page 419 and 420:
CMS-1403-FC building in which the b
Page 421 and 422:
CMS-1403-FC were concerned that thi
Page 423 and 424:
CMS-1403-FC supplier will be subjec
Page 425 and 426:
CMS-1403-FC numerical test for the
Page 427 and 428:
CMS-1403-FC space in which the orde
Page 429 and 430:
CMS-1403-FC disadvantage nonproblem
Page 431 and 432:
CMS-1403-FC would be simpler to not
Page 433 and 434:
CMS-1403-FC IDTF standards in §410
Page 435 and 436:
CMS-1403-FC that rule, the Governme
Page 437 and 438:
CMS-1403-FC with comment period, th
Page 439 and 440:
CMS-1403-FC 1842(n)(1) of the Act,
Page 441 and 442:
CMS-1403-FC anti-markup provisions
Page 443 and 444:
CMS-1403-FC her group practice woul
Page 445 and 446:
CMS-1403-FC A commenter representin
Page 447 and 448:
CMS-1403-FC tenens arrangements cou
Page 449 and 450:
CMS-1403-FC other supplier. We are
Page 451 and 452:
CMS-1403-FC on pathology reports or
Page 453 and 454:
CMS-1403-FC patients. According to
Page 455 and 456:
CMS-1403-FC from sharing a practice
Page 457 and 458:
CMS-1403-FC Group A orders the TC a
Page 459 and 460:
CMS-1403-FC physicians the flexibil
Page 461 and 462:
CMS-1403-FC Response: We recognize
Page 463 and 464:
CMS-1403-FC Response: Because the d
Page 465 and 466:
CMS-1403-FC limited by the proposed
Page 467 and 468:
CMS-1403-FC Response: With respect
Page 469 and 470:
CMS-1403-FC to focus on the medical
Page 471 and 472:
CMS-1403-FC service” approach bec
Page 473 and 474:
CMS-1403-FC have the right to recei
Page 475 and 476:
CMS-1403-FC 2 approach finalized he
Page 477 and 478:
CMS-1403-FC the ordering physician
Page 479 and 480:
CMS-1403-FC ensure an adequate nexu
Page 481 and 482:
CMS-1403-FC entity” should be def
Page 483 and 484:
CMS-1403-FC between the performing
Page 485 and 486:
CMS-1403-FC supplier” to encompas
Page 487 and 488:
CMS-1403-FC to continue to provide
Page 489 and 490:
CMS-1403-FC requirements of the Alt
Page 491 and 492:
CMS-1403-FC supervised in the offic
Page 493 and 494:
CMS-1403-FC reducing access to care
Page 495 and 496:
CMS-1403-FC commenter supported ado
Page 497 and 498:
CMS-1403-FC “outside supplier,”
Page 499 and 500:
CMS-1403-FC group could recover onl
Page 501 and 502:
CMS-1403-FC incurred, thereby compe
Page 503 and 504:
CMS-1403-FC needed to provide the t
Page 505 and 506:
CMS-1403-FC performing supplier for
Page 507 and 508:
CMS-1403-FC providers, the services
Page 509 and 510:
CMS-1403-FC commenter also expresse
Page 511 and 512:
CMS-1403-FC overutilization of in-o
Page 513 and 514:
CMS-1403-FC provisions for single-s
Page 515 and 516:
CMS-1403-FC we did not propose such
Page 517 and 518:
CMS-1403-FC and PCs supervised or p
Page 519 and 520:
CMS-1403-FC provisions will not app
Page 521 and 522:
CMS-1403-FC (Pub. L. 110-173) (MMSE
Page 523 and 524:
CMS-1403-FC reporting data on quali
Page 525 and 526:
CMS-1403-FC PQRI and a more detaile
Page 527 and 528:
CMS-1403-FC and our responses to th
Page 529 and 530:
CMS-1403-FC provisions of the Priva
Page 531 and 532:
CMS-1403-FC reducing eligible profe
Page 533 and 534:
CMS-1403-FC administrative or judic
Page 535 and 536:
CMS-1403-FC professionals who did n
Page 537 and 538:
CMS-1403-FC base the incentive paym
Page 539 and 540:
CMS-1403-FC A few commenters noted
Page 541 and 542:
CMS-1403-FC administrative burden t
Page 543 and 544:
CMS-1403-FC requested that more det
Page 545 and 546:
CMS-1403-FC incentive payments for
Page 547 and 548:
CMS-1403-FC December 31, 2009 and J
Page 549 and 550:
CMS-1403-FC the reporting period fo
Page 551 and 552:
CMS-1403-FC proposed to carry forwa
Page 553 and 554:
CMS-1403-FC measures group is appli
Page 555 and 556:
CMS-1403-FC measures results and nu
Page 557 and 558:
CMS-1403-FC (Delmarva Foundation fo
Page 559 and 560:
CMS-1403-FC registries to report on
Page 561 and 562:
CMS-1403-FC reporting options for r
Page 563 and 564:
CMS-1403-FC incentive payment for P
Page 565 and 566:
CMS-1403-FC to report 2009 PQRI qua
Page 567 and 568:
CMS-1403-FC Comment: We received nu
Page 569 and 570:
CMS-1403-FC Comment: One comment su
Page 571 and 572:
CMS-1403-FC quality measures result
Page 573 and 574:
CMS-1403-FC requirements listed on
Page 575 and 576:
CMS-1403-FC a data submission vendo
Page 577 and 578:
CMS-1403-FC As we stated in the CY
Page 579 and 580:
CMS-1403-FC whether eligible profes
Page 581 and 582:
CMS-1403-FC ● Agree that the regi
Page 583 and 584:
CMS-1403-FC soon thereafter as is t
Page 585 and 586:
CMS-1403-FC Comment: We received ma
Page 587 and 588:
Page 589 and 590:
CMS-1403-FC additional 2.0 percent
Page 591 and 592:
CMS-1403-FC EHRs in 2009. The measu
Page 593 and 594:
CMS-1403-FC i. Overview and Summary
Page 595 and 596:
CMS-1403-FC voluntary consensus sta
Page 597 and 598:
Page 599 and 600:
CMS-1403-FC the AMA-PCPI should be
Page 601 and 602:
CMS-1403-FC are appropriate and do
Page 603 and 604:
CMS-1403-FC to make any changes to
Page 605 and 606:
CMS-1403-FC post the measures for p
Page 607 and 608:
CMS-1403-FC beneficiaries. We now h
Page 609 and 610:
CMS-1403-FC identified in Tables 15
Page 611 and 612:
CMS-1403-FC important difference in
Page 613 and 614:
CMS-1403-FC not use Measures #73 Ca
Page 615 and 616:
CMS-1403-FC measures, but which are
Page 617 and 618:
CMS-1403-FC with comment period. Ho
Page 619 and 620:
CMS-1403-FC ● Measure #41 Osteopo
Page 621 and 622:
CMS-1403-FC professional to simply
Page 623 and 624:
CMS-1403-FC measures. We consider t
Page 625 and 626:
CMS-1403-FC Measure Number and Titl
Page 627 and 628:
CMS-1403-FC Measure Number and Titl
Page 629 and 630:
CMS-1403-FC ● Measure #120 CKD: A
Page 631 and 632:
CMS-1403-FC For the 2009 PQRI quali
Page 633 and 634:
CMS-1403-FC rule indicated that the
Page 635 and 636:
CMS-1403-FC Response: As suggested
Page 637 and 638:
CMS-1403-FC required for the measur
Page 639 and 640:
CMS-1403-FC ● Achievement of NQF
Page 641 and 642:
CMS-1403-FC These additional measur
Page 643 and 644:
CMS-1403-FC We did not include this
Page 645 and 646:
CMS-1403-FC Comment: Many commenter
Page 647 and 648:
CMS-1403-FC groups must have a part
Page 649 and 650:
CMS-1403-FC selected for inclusion
Page 651 and 652:
CMS-1403-FC Measure Title Measure S
Page 653 and 654:
CMS-1403-FC proposed HIV/AIDS measu
Page 655 and 656:
CMS-1403-FC set of denominator spec
Page 657 and 658:
CMS-1403-FC results, for this purpo
Page 659 and 660:
CMS-1403-FC informed decision-makin
Page 661 and 662:
Page 663 and 664:
CMS-1403-FC prior commitments that
Page 665 and 666:
CMS-1403-FC groups who successfully
Page 667 and 668:
CMS-1403-FC ● Eligible profession
Page 669 and 670:
CMS-1403-FC patients, families, and
Page 671 and 672:
CMS-1403-FC that have satisfactoril
Page 673 and 674:
CMS-1403-FC e-prescribing quality m
Page 675 and 676:
CMS-1403-FC Douglas S. and Friedman
Page 677 and 678:
CMS-1403-FC subsequent year, if the
Page 679 and 680:
CMS-1403-FC eligible professional f
Page 681 and 682:
CMS-1403-FC and is included in the
Page 683 and 684:
CMS-1403-FC The measure becomes app
Page 685 and 686:
CMS-1403-FC is, Measure #125) appli
Page 687 and 688:
CMS-1403-FC outpatient setting. Whi
Page 689 and 690:
CMS-1403-FC ability of an electroni
Page 691 and 692:
CMS-1403-FC October 2005 (hereinaft
Page 693 and 694:
CMS-1403-FC We are aware that there
Page 695 and 696:
CMS-1403-FC provided during the enc
Page 697 and 698:
CMS-1403-FC denominator of a measur
Page 699 and 700:
CMS-1403-FC cases. If the is determ
Page 701 and 702:
CMS-1403-FC during 2009; and (3) wh
Page 703 and 704:
CMS-1403-FC on this quality measure
Page 705 and 706:
CMS-1403-FC become effective until
Page 707 and 708:
CMS-1403-FC and CY 2007 PFS final r
Page 709 and 710:
CMS-1403-FC directly affected by th
Page 711 and 712:
CMS-1403-FC requires advanced pract
Page 713 and 714:
CMS-1403-FC applaud CMS for recogni
Page 715 and 716:
CMS-1403-FC standardization of DNP
Page 717 and 718:
CMS-1403-FC for the most part, been
Page 719 and 720:
CMS-1403-FC that the requirement fo
Page 721 and 722:
CMS-1403-FC degree in radiologic te
Page 723 and 724:
CMS-1403-FC the physicians that fur
Page 725 and 726:
CMS-1403-FC is associated with a te
Page 727 and 728:
CMS-1403-FC facility in which a tec
Page 729 and 730:
CMS-1403-FC by the Medicare program
Page 731 and 732:
CMS-1403-FC pressure (CPAP)” and
Page 733 and 734:
CMS-1403-FC for example chronic obs
Page 735 and 736:
CMS-1403-FC thus they believe leadi
Page 737 and 738:
CMS-1403-FC Excepting attended faci
Page 739 and 740:
CMS-1403-FC supplier separately. Ho
Page 741 and 742:
CMS-1403-FC final rule’s provisio
Page 743 and 744:
CMS-1403-FC as a DME supplier and p
Page 745 and 746:
CMS-1403-FC Moreover, given our gen
Page 747 and 748:
CMS-1403-FC resources and infrastru
Page 749 and 750:
Page 751 and 752:
CMS-1403-FC organization through a
Page 753 and 754:
CMS-1403-FC After reviewing the pub
Page 755 and 756:
CMS-1403-FC the nonparticipating ho
Page 757 and 758:
CMS-1403-FC be costly and burdensom
Page 759 and 760:
CMS-1403-FC adopting our proposal t
Page 761 and 762:
CMS-1403-FC We are not persuaded to
Page 763 and 764:
CMS-1403-FC §424.36(b)(6)(ii)(C)(2
Page 765 and 766:
CMS-1403-FC be made to obtain the s
Page 767 and 768:
CMS-1403-FC willing to sign at the
Page 769 and 770:
CMS-1403-FC and not suppliers, may
Page 771 and 772:
CMS-1403-FC crew member would have
Page 773 and 774:
CMS-1403-FC In order to determine f
Page 775 and 776:
CMS-1403-FC retrieval of the variou
Page 777 and 778:
CMS-1403-FC plan that demonstrates
Page 779 and 780:
CMS-1403-FC conviction, license sus
Page 781 and 782:
CMS-1403-FC The following is a summ
Page 783 and 784:
CMS-1403-FC faith reduces the time
Page 785 and 786:
CMS-1403-FC suspension or revocatio
Page 787 and 788:
CMS-1403-FC 9 percent per year. 2 I
Page 789 and 790:
CMS-1403-FC magnetic resonance imag
Page 791 and 792:
CMS-1403-FC Committee for Quality A
Page 793 and 794:
CMS-1403-FC measures in CMS’ VBP
Page 795 and 796:
CMS-1403-FC the Boston program site
Page 797 and 798:
CMS-1403-FC conditions that are hig
Page 799 and 800:
CMS-1403-FC reports? ● Do physici
Page 801 and 802:
CMS-1403-FC most Evaluation and Man
Page 803 and 804:
CMS-1403-FC III. Medicare Improveme
Page 805 and 806:
CMS-1403-FC Specifically, section 1
Page 807 and 808:
CMS-1403-FC period. The public will
Page 809 and 810:
CMS-1403-FC Section 101(b) of the M
Page 811 and 812:
CMS-1403-FC 1 year after the effect
Page 813 and 814:
CMS-1403-FC applies to both adult m
Page 815 and 816:
CMS-1403-FC period is limited to th
Page 817 and 818:
CMS-1403-FC 2007 through 2010. In a
Page 819 and 820:
CMS-1403-FC Section 1848(m)(3)(D) o
Page 821 and 822:
CMS-1403-FC In addition to the prov
Page 823 and 824:
CMS-1403-FC during the 2009 and 201
Page 825 and 826:
CMS-1403-FC prescribers for 2009 ar
Page 827 and 828:
CMS-1403-FC requirement by making a
Page 829 and 830:
CMS-1403-FC continue to bill the Me
Page 831 and 832:
CMS-1403-FC therapy and speech-lang
Page 833 and 834:
CMS-1403-FC ● Section 1835(a) of
Page 835 and 836:
CMS-1403-FC The amendments made by
Page 837 and 838:
CMS-1403-FC national associations a
Page 839 and 840:
CMS-1403-FC On November 9, 2006, we
Page 841 and 842:
CMS-1403-FC our regulations states
Page 843 and 844:
CMS-1403-FC rental period. The supp
Page 845 and 846:
CMS-1403-FC reasonable useful lifet
Page 847 and 848:
CMS-1403-FC to use the equipment be
Page 849 and 850:
CMS-1403-FC oxygen contents after t
Page 851 and 852:
CMS-1403-FC the oxygen contents and
Page 853 and 854:
CMS-1403-FC Section 414.210(e)(2) a
Page 855 and 856:
CMS-1403-FC reported to us that, ba
Page 857 and 858:
CMS-1403-FC non-routine maintenance
Page 859 and 860:
CMS-1403-FC As a result, we will ma
Page 861 and 862:
CMS-1403-FC 31, 2009 amounts for gr
Page 863 and 864:
CMS-1403-FC under section 332(a)(1)
Page 865 and 866:
CMS-1403-FC furnishing services via
Page 867 and 868:
CMS-1403-FC required to furnish dir
Page 869 and 870:
CMS-1403-FC mental health services
Page 871 and 872:
CMS-1403-FC Skilled Nursing Facilit
Page 873 and 874:
CMS-1403-FC where the SNF resident
Page 875 and 876:
CMS-1403-FC describes the methodolo
Page 877 and 878:
CMS-1403-FC The RUC has created the
Page 879 and 880:
CMS-1403-FC Response: Although we r
Page 881 and 882:
CMS-1403-FC occurring code pairs. T
Page 883 and 884:
CMS-1403-FC a standing panel of exp
Page 885 and 886:
CMS-1403-FC extraction of the assoc
Page 887 and 888:
CMS-1403-FC TABLE 26: AMA RUC Recom
Page 889 and 890:
CMS-1403-FC AMA RUC Rec Site of Ser
Page 891 and 892:
Page 893 and 894:
Page 895 and 896:
CMS-1403-FC Note: The RUC reviewed
Page 897 and 898:
CMS-1403-FC C. Interim 2008 Codes 1
Page 899 and 900:
CMS-1403-FC national noncoverage de
Page 901 and 902:
CMS-1403-FC CPT codes for 2008. In
Page 903 and 904:
CMS-1403-FC associated work RVUs, t
Page 905 and 906:
CMS-1403-FC CPT 1 AMA RUC Work RVU
Page 907 and 908:
CMS-1403-FC # New CPT code. 1 All C
Page 909 and 910:
CMS-1403-FC ● 27218, Open treatme
Page 911 and 912:
CMS-1403-FC RVUs for G0412; 15.73 w
Page 913 and 914:
CMS-1403-FC Therefore, we disagree
Page 915 and 916:
CMS-1403-FC generally contractor pr
Page 917 and 918:
CMS-1403-FC In addition, we believe
Page 919 and 920:
CMS-1403-FC RVU for CPT code 93289
Page 921 and 922:
CMS-1403-FC time to better understa
Page 923 and 924:
CMS-1403-FC ● 93306, Echocardiogr
Page 925 and 926:
CMS-1403-FC Although not discussed
Page 927 and 928:
CMS-1403-FC for New and Revised 200
Page 929 and 930:
CMS-1403-FC item. In addition, the
Page 931 and 932:
CMS-1403-FC 90956, 90957, 90958, 90
Page 933 and 934:
CMS-1403-FC place of these two new
Page 935 and 936:
CMS-1403-FC beneficiary or any othe
Page 937 and 938:
CMS-1403-FC ● Adding the followin
Page 939 and 940:
CMS-1403-FC Tables 29 and 30 also i
Page 941 and 942:
CMS-1403-FC RADIOLOGY AND CERTAIN O
Page 943 and 944:
CMS-1403-FC 93320 Doppler echo exam
Page 945 and 946:
CMS-1403-FC index data, that the hi
Page 947 and 948:
CMS-1403-FC TABLE 32: Increase in t
Page 949 and 950:
CMS-1403-FC C. The Update Adjustmen
Page 951 and 952:
CMS-1403-FC end of the prior year a
Page 953 and 954:
CMS-1403-FC CY 2009, the statute re
Page 955 and 956:
CMS-1403-FC Actual08 = Estimated Ac
Page 957 and 958:
CMS-1403-FC 1848(f)(3)(C)(i) of the
Page 959 and 960:
CMS-1403-FC ● Screening mammograp
Page 961 and 962:
CMS-1403-FC payments while promotin
Page 963 and 964:
CMS-1403-FC E. Final Sustainable Gr
Page 965 and 966:
CMS-1403-FC included in the SGR (us
Page 967 and 968:
CMS-1403-FC that this figure will c
Page 969 and 970:
CMS-1403-FC physicians' services in
Page 971 and 972:
CMS-1403-FC imaging services, the M
Page 973 and 974:
CMS-1403-FC CY 2007. Table 42 illus
Page 975 and 976:
CMS-1403-FC year to the entire year
Page 977 and 978:
CMS-1403-FC the CF. Therefore, this
Page 979 and 980:
CMS-1403-FC estimate that CY 2009 R
Page 981 and 982:
CMS-1403-FC Table 44: Calculation o
Page 983 and 984:
CMS-1403-FC XI. Payment for Certain
Page 985 and 986:
CMS-1403-FC In the Competitive Acqu
Page 987 and 988:
CMS-1403-FC glasses, hand magnifier
Page 989 and 990:
CMS-1403-FC Our interpretation of t
Page 991 and 992:
CMS-1403-FC Response: We understand
Page 993 and 994:
CMS-1403-FC defines “eyeglass”
Page 995 and 996:
CMS-1403-FC this statutory exclusio
Page 997 and 998:
CMS-1403-FC advances in the use of
Page 999 and 1000:
CMS-1403-FC is paid for his or her
Page 1001 and 1002:
CMS-1403-FC XII. Provisions of the
Page 1003 and 1004:
CMS-1403-FC these RUC recommendatio
Page 1005 and 1006:
CMS-1403-FC services. We believe a
Page 1007 and 1008:
CMS-1403-FC Section 144(b) of the M
Page 1009 and 1010:
CMS-1403-FC rulemaking with respect
Page 1011 and 1012:
CMS-1403-FC (respectively) of this
Page 1013 and 1014:
CMS-1403-FC completing and submitti
Page 1015 and 1016:
CMS-1403-FC §424.516(d)(1). Additi
Page 1017 and 1018:
CMS-1403-FC to several associated i
Page 1019 and 1020:
CMS-1403-FC incentive payment for 2
Page 1021 and 1022:
CMS-1403-FC year of PQRI reporting)
Page 1023 and 1024:
CMS-1403-FC Based on the assumption
Page 1025 and 1026:
CMS-1403-FC these activities for th
Page 1027 and 1028:
CMS-1403-FC per hour, we estimate t
Page 1029 and 1030:
CMS-1403-FC Because of the large nu
Page 1031 and 1032:
CMS-1403-FC threshold, and hence al
Page 1033 and 1034:
CMS-1403-FC shoes, the regulation i
Page 1035 and 1036:
CMS-1403-FC with comment period for
Page 1037 and 1038:
CMS-1403-FC substance of State laws
Page 1039 and 1040:
CMS-1403-FC $20 million from what e
Page 1041 and 1042:
CMS-1403-FC ● Impact of Work RVU
Page 1043 and 1044:
CMS-1403-FC imaging services from t
Page 1045 and 1046:
CMS-1403-FC ● Impact of section 1
Page 1047 and 1048:
CMS-1403-FC management, could have
Page 1049 and 1050:
CMS-1403-FC Table 50 illustrates, f
Page 1051 and 1052:
CMS-1403-FC CPT/ HCPCS Mod Descript
Page 1053 and 1054:
CMS-1403-FC impact associated with
Page 1055 and 1056:
CMS-1403-FC The fourth column shows
Page 1057 and 1058:
CMS-1403-FC the CY 2007 claims. The
Page 1059 and 1060:
CMS-1403-FC 1059 4/This column show
Page 1061 and 1062:
CMS-1403-FC requirements is to allo
Page 1063 and 1064:
CMS-1403-FC This amendment of the e
Page 1065 and 1066:
CMS-1403-FC 4 minutes per call, lab
Page 1067 and 1068:
CMS-1403-FC e-prescribing and who m
Page 1069 and 1070:
CMS-1403-FC anti-markup provisions
Page 1071 and 1072:
CMS-1403-FC approximately $50 per h
Page 1073 and 1074:
CMS-1403-FC e-prescribing measure i
Page 1075 and 1076:
CMS-1403-FC we estimate that each e
Page 1077 and 1078:
CMS-1403-FC P. Prohibition Concerni
Page 1079 and 1080:
CMS-1403-FC that provides a calcula
Page 1081 and 1082:
CMS-1403-FC treatment) that occur a
Page 1083 and 1084:
CMS-1403-FC locality (+5.37 percent
Page 1085 and 1086:
CMS-1403-FC additional rental payme
Page 1087 and 1088:
CMS-1403-FC T. Competitive Acquisit
Page 1089 and 1090:
CMS-1403-FC Program; II.T. Electron
Page 1091 and 1092:
CMS-1403-FC which means that in 200
Page 1093 and 1094:
CMS-1403-FC List of Subjects 42 CFR
Page 1095 and 1096:
CMS-1403-FC For the reasons set for
Page 1097 and 1098:
CMS-1403-FC (1) Except as specified
Page 1099 and 1100:
CMS-1403-FC pressure, a visual acui
Page 1101 and 1102:
CMS-1403-FC (ii) A speech-language
Page 1103 and 1104:
CMS-1403-FC during the hours that t
Page 1105 and 1106:
CMS-1403-FC (i) Be certified as a n
Page 1107 and 1108:
CMS-1403-FC 14. Section 410.155 is
Page 1109 and 1110:
CMS-1403-FC prostate cancer screeni
Page 1111 and 1112:
CMS-1403-FC B. Amending the definit
Page 1113 and 1114:
CMS-1403-FC The revisions and addit
Page 1115 and 1116:
CMS-1403-FC or institution other th
Page 1117 and 1118:
CMS-1403-FC substantially all (whic
Page 1119 and 1120:
CMS-1403-FC psychiatric diagnostic
Page 1121 and 1122:
CMS-1403-FC repairing, maintaining,
Page 1123 and 1124:
CMS-1403-FC B. Deleting paragraph (
Page 1125 and 1126:
CMS-1403-FC during any period of me
Page 1127 and 1128:
CMS-1403-FC (c)(1). A. Revising the
Page 1129 and 1130:
CMS-1403-FC * * * * * (b) * * * (2)
Page 1131 and 1132:
CMS-1403-FC assigned to such drug p
Page 1133 and 1134:
CMS-1403-FC 33. In §415.130(d), th
Page 1135 and 1136:
CMS-1403-FC (6) An ambulance provid
Page 1137 and 1138:
CMS-1403-FC §424.57 Special paymen
Page 1139 and 1140:
CMS-1403-FC Final adverse action me
Page 1141 and 1142:
CMS-1403-FC (b) Reporting requireme
Page 1143 and 1144:
CMS-1403-FC of Medicare billing pri
Page 1145 and 1146:
CMS-1403-FC (a) Physicians, nonphys
Page 1147 and 1148:
CMS-1403-FC * * * * * (g) Effective
Page 1149 and 1150:
CMS-1403-FC that meet the qualifica
Page 1151 and 1152:
CMS-1403-FC (3) Have equivalent tra
Page 1153 and 1154:
CMS-1403-FC §485.711 Condition of
Page 1155 and 1156:
CMS-1403-FC Subpart C--Conditions f
Page 1157 and 1158:
CMS-1403-FC Authority: Catalog of F
Page 1159 and 1160:
CMS-1403-FC Addendum B means that C
Page 1161 and 1162:
CMS-1403-FC which they are incident
Page 1163 and 1164:
CMS-1403-FC T = There are RVUs for
Page 1165 and 1166:
CMS-1403-FC ADDENDUM B: Relative Va
Page 1167 and 1168:
CMS-1403-FC Physi- cian Work Fully
Page 1169 and 1170:
Page 1171 and 1172:
Page 1173 and 1174:
Page 1175 and 1176:
Page 1177 and 1178:
Page 1179 and 1180:
Page 1181 and 1182:
Page 1183 and 1184:
Page 1185 and 1186:
Page 1187 and 1188:
Page 1189 and 1190:
Page 1191 and 1192:
Page 1193 and 1194:
Page 1195 and 1196:
Page 1197 and 1198:
Page 1199 and 1200:
Page 1201 and 1202:
Page 1203 and 1204:
Page 1205 and 1206:
Page 1207 and 1208:
Page 1209 and 1210:
Page 1211 and 1212:
Page 1213 and 1214:
Page 1215 and 1216:
Page 1217 and 1218:
Page 1219 and 1220:
Page 1221 and 1222:
Page 1223 and 1224:
Page 1225 and 1226:
Page 1227 and 1228:
Page 1229 and 1230:
Page 1231 and 1232:
Page 1233 and 1234:
Page 1235 and 1236:
Page 1237 and 1238:
Page 1239 and 1240:
Page 1241 and 1242:
Page 1243 and 1244:
Page 1245 and 1246:
Page 1247 and 1248:
Page 1249 and 1250:
Page 1251 and 1252:
Page 1253 and 1254:
Page 1255 and 1256:
Page 1257 and 1258:
Page 1259 and 1260:
Page 1261 and 1262:
Page 1263 and 1264:
Page 1265 and 1266:
Page 1267 and 1268:
Page 1269 and 1270:
Page 1271 and 1272:
Page 1273 and 1274:
Page 1275 and 1276:
Page 1277 and 1278: CMS-1403-FC Physi- cian Work Fully
Page 1327: CMS-1403-FC Physi- cian Work Fully
Page 1369 and 1370: CMS-1403-FC CPT 1 / HCPCS Mod Statu
Page 1371 and 1372: CMS-1403-FC CPT 1 / HCPCS Mod Statu
Page 1375 and 1376: CMS-1403-FC Contractor Locality Loc
Page 1377 and 1378: CMS-1403-FC ADDENDUM E: 2009 Geogra
Page 1379 and 1380:
CMS-1403-FC Work** PE MP Contractor
Page 1381 and 1382:
CMS-1403-FC 70492 Ct soft tissue ne
Page 1383 and 1384:
CMS-1403-FC 73201 Ct upper extremit
Page 1385 and 1386:
CMS-1403-FC 10780 10900 11020 11100
Page 1387 and 1388:
CMS-1403-FC 12420 12540 12580 12620
Page 1389 and 1390:
CMS-1403-FC 14060 14260 14484 14500
Page 1391 and 1392:
CMS-1403-FC 16820 16860 16940 16974
Page 1393 and 1394:
CMS-1403-FC 17980 18020 18140 18580
Page 1395 and 1396:
CMS-1403-FC 19804 20020 20100 20220
Page 1397 and 1398:
CMS-1403-FC 22500 22520 22540 22660
Page 1399 and 1400:
CMS-1403-FC 25020 25060 25180 25260
Page 1401 and 1402:
CMS-1403-FC 26980 27060 27100 27140
Page 1403 and 1404:
CMS-1403-FC 28700 28740 28940 29020
Page 1405 and 1406:
CMS-1403-FC 30860 30980 31020 31084
Page 1407 and 1408:
CMS-1403-FC 33140 33260 33340 33460
Page 1409 and 1410:
CMS-1403-FC 35300 35380 35644 35660
Page 1411 and 1412:
CMS-1403-FC 37340 37380 37460 37620
Page 1413 and 1414:
CMS-1403-FC 39300 39340 39380 39460
Page 1415 and 1416:
CMS-1403-FC 40580 40660 40900 40980
Page 1417 and 1418:
CMS-1403-FC 41940 41980 Sabana Gran
Page 1419 and 1420:
CMS-1403-FC 43340 43580 43620 43780
Page 1421 and 1422:
CMS-1403-FC 45940 46060 46140 46220
Page 1423 and 1424:
CMS-1403-FC 47940 48140 48260 48300
Page 1425 and 1426:
CMS-1403-FC 1425
Page 1427 and 1428:
CMS-1403-FC CBSA Code Nonurban Area
Page 1429 and 1430:
CMS-1403-FC HCPCS Descriptor 71260
Page 1431 and 1432:
Page 1433 and 1434:
Page 1435 and 1436:
Page 1437 and 1438:
CMS-1403-FC 78122 Blood volume 7813
Page 1439 and 1440:
CMS-1403-FC 96125 Cognitive test by
Page 1441 and 1442:
CMS-1403-FC 70240 X-ray exam, pitui
Page 1443 and 1444:
CMS-1403-FC 72120 X-ray exam of low
Page 1445 and 1446:
CMS-1403-FC 73720 Mri lwr extremity
Page 1447 and 1448:
CMS-1403-FC 76856 Us exam, pelvic,
Page 1449 and 1450:
CMS-1403-FC 78456 Acute venous thro
Page 1451 and 1452:
CMS-1403-FC 93320 Doppler echo exam
Page 1453 and 1454:
CMS-1403-FC A9571 Indium In-111 aut
Page 1455 and 1456:
CMS-1403-FC 77333 Radiation treatme
Page 1457 and 1458:
CMS-1403-FC C2638 Brachytx, strande
Page 1459:
CMS-1403-FC P3000 Screen pap by tec
show all

Notice: This CMS-approved document has been submitted - Philips ...

Create successful ePaper yourself

Delete template?

Save as template?